International Journal of Clinical Pharmacy

Article	Citations
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”	73
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia	63
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies	51
Implementation fidelity of a pharmacist-led intervention program to improve a high serum phosphate concentration in haemodialysis patients: a mixed-methods study	47
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes	42
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review	40
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study	35
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer	34
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children	34
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study	34
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial	30
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study	30
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'	30
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study	29
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study	28
Non-cardiovascular medication and readmission for heart failure: an observational cohort study	27
Sedative co-medication patterns across frailty states in people with HIV: a network-based study	25
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials	25
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country	25
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units	25
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer	23
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years	23
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs	23
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients	23
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey	22

Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	21
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study	21
Effects of children’s criteria for identifying potentially inappropriate prescribing on prescription review by pharmacists: a before-after study	20
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis	20
Conversational agents for pharmaceutical use: insights from the eCCo database	20
Impact of Australian home medicines reviews on continuous polypharmacy and associated costs among older women: a cohort study	19
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study	19
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure	19
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List	18
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity	18
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors	17
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey	17
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations	17
Detection and management of pill swallowing difficulties: a community pharmacy-based observational study	16
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups	16
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care	16
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study	15
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized	15
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes	14
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study	14
Medication supply at hospital discharge via community pharmacy: a quality improvement study	14
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis	13
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram	13
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study	13
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care	13
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence	13
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study	13
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	13
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions	13
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions	13
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data	13
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy	13
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases	13
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study	12
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study	12
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study	12
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines	12
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review	11
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry	11
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences	11
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China	11
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives	11
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums	11
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study	11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis	11
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults	11
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)	11
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”	11
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study	10
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial	10

Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities	10
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma	10
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study	10
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance	10
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study	10
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C	10
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”	10
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital	10
Building an effective medicines optimisation model: a health system approach	10
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)	10
Population pharmacokinetics of imipenem and target attainment of pharmacokinetic/pharmacodynamic indices in Chinese adults with febrile neutropenia and hematological malignancies	10
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study	10
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand	9
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system	9
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China	9
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital	9
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr	9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu	9
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources	9
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study	9
A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system	9
Evaluating an integrated clinical pharmacist model in a geriatric day hospital: a prospective single-centre observational study	9
A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database	9
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study	9
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports	9
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)	9
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings	9
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system	8
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care	8
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study	8
Perceived importance of tailored education to prevent second victim phenomenon in clinical pharmacy practice: a focus group study with community pharmacists	8
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists	8
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’	8
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study	8
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study	8
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database	8
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials	8
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic	8
Evaluating the quality, feasibility and patient satisfaction of medication history taking by telephone for patients with scheduled admissions: a pilot study	8
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study	8
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries	8
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso	8
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation	8
Implementation of pharmacist-led deprescribing in collaborative primary care settings	8
Risk factors for potentially inappropriate medication use in older adults: a cohort study	8
The effect of empagliflozin on renal outcomes compared to sitagliptin with type 2 diabetes: target trial emulation using electronic medical records	8
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis	8
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study	8
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study	7
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study	7
Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 2022	7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy	7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study	7
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study	7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care	7
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review	7
Accuracy of best possible medication histories by pharmacy students: an observational study	7
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population	7
Disparities associated with race and ethnicity in pain management: a scoping review	7
ADHD prescribing: national findings of children and adolescents attending mental health services in Ireland	7
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database	7
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study	7
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers	7
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review	7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists	7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C	7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis	7
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System	7
Developing a theory-based behavior change intervention to improve the prescription of surgical prophylaxis	6
A qualitative exploration of the impact of a hospital electronic prescribing and medicines administration (HEPMA) protocol on junior doctor confidence and competence to prescribe end-of-life care medi	6
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan	6
Evaluating biosimilars: safety, efficacy, and regulatory considerations in clinical studies	6
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study	6
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review	6
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study	6
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach	6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study	6
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	6
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national	6
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence	6

Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study	6
Medicines-related interventions to support safe transitions for care home residents post hospital discharge: Do hospital-delivered interventions have a role?	6
Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour	6
Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials	6
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist	6
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula	6
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study	6
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-	6
“A little bit more looking…listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy	6
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis	6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	6
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study	6
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte	6
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study	6
Clinical prediction of sodium valproate-induced movement disorders in hospitalized patients: a nomogram-based model using real-world data	6
Thank you from the Editor-in-Chief	6
European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper	6
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings	6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study	6
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study	6
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023	6
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China	6
Effectiveness and safety of different antiplatelet therapies for minor ischemic stroke or high-risk transient ischemic attack: a systematic review and network meta-analysis	6
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis	6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study	6
Model-informed precision dosing of vancomycin in clinical practice: an intervention development study	5
Patients’ perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence	5
Barriers and enablers to switching from a solid to a liquid formulation of Parkinson’s medication: a theory-based mixed methods investigation	5
Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	5
An economic evaluation of vial sharing of expensive drugs in automated compounding	5
Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment	5
Effect and associated factors of a clinical pharmacy model in the incidence of medication errors in the hospital Pablo Tobón Uribe eacpharmodel study: stepped wedge randomized controlled Trial (NCT033	5
Implementing a clinical pharmacy intervention for older adult inpatients with chronic non-cancer pain: a feasibility study	5
Impact of medicine shortages on hospital practice: role of a multidisciplinary medicine shortages team	5
The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study	5
Overcoming challenges: implementing and scaling clinical pharmacy education and practice in the Republic of Srpska/Bosnia and Herzegovina	5
Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study	5
Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study	5
Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory	5
Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study	5
Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies	5
Sentiment analysis in medication adherence: using ruled-based and artificial intelligence-driven algorithms to understand patient medication experiences	5
General practice-based undergraduate pharmacy longitudinal clerkship: a theoretically underpinned qualitative evaluation	5
Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study	5
Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe	5
Risk factors for linezolid-induced thrombocytopenia in adult inpatients	5
Addressing potentially inappropriate prescribing in care homes: regional evaluation of a pharmacist-led model in Northern Ireland	5
Additional value of a triggerlist as selection criterion in identifying patients at high risk of medication-related hospital admission: a retrospective cohort study	5
A model for identifying potentially inappropriate medication used in older people with dementia: a machine learning study	5
Correction to: Cost-effectiveness of check of medication appropriateness: methodological approach	5
Just a ‘romantic idea’? A theory-based interview study on medication review implementation with pharmacy owners	5
Relative effectiveness and gastrointestinal safety of NSAIDs being prescribed for upper respiratory tract infections: an explorative cohort study in primary care	5
Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database	5
Colorectal cancer patients’ experiences with antineoplastic agents from the perspective of their significant others: a longitudinal qualitative study	5
The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review	5
Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study	5
Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool	5
Diagnostic evaluation of hypersensitivity reactions to arylpropionic acid derivatives: a descriptive observational study focusing on clinical characteristics and potential risk factors in children	5
Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study	5
Climate conscious pharmacy practice: a qualitative interview study with pharmacists in the context of respiratory health care	5
Optimizing chronic disease management through community-based pharmaceutical care for older adults in China: a systematic review and meta-analysis of randomized controlled trials	5
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study	5
Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	5
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach	5
Learnings from research on artificial intelligence enabled solutions in clinical pharmacy practice and education	5
Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-intervention stu	5
Community pharmacists' perceptions of their challenges in relation to older adults prescribed psychotropic medications: a focus-group study	5
Point-of-care HIV and hepatitis screening in community pharmacies: a quantitative and qualitative study	5
Improving medication adherence in the community: a purposive umbrella review of effective patient-directed interventions that are readily implementable in the United Kingdom National Health Service	5
Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists	5
Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain	4
Efficacy and safety of Jingqianshu granules in patients with premenstrual syndrome: a multicenter, randomized, double-blind, placebo-controlled trial	4
Correction to: Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	4
Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study	4
Comparison of prioritisation algorithms for the selection of patients for medication reviews in the emergency department: a cross-sectional study	4
Community pharmacists’ views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study	4
Correction to: The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled	4
Optimizing vancomycin dosing in pediatrics: a machine learning approach to predict trough concentrations in children under four years of age	4
Effects of statin use on primary patency, mortality, and limb loss in patients undergoing lower-limb arterial angioplasty: a systematic review and meta-analysis	4
Investigating digital determinants shaping pharmacists’ preparedness for interoperability and health informatics practice evolution: a systematic review	4
Barriers and facilitators to implementing polypharmacy management frameworks: a theory based qualitative exploration of key stakeholders	4
Evaluation of a multifaceted medication review in older patients in the outpatient setting: a before-and-after study	4
Development and evaluation of pharmacist-provided teach-back medication counselling at hospital discharge	4
Contextual factors influencing medicines-related interventions to support safe transitions for care home residents post hospital discharge: a systematic review and meta-ethnographic synthesis	4
Analysis of the association between Janus kinase inhibitors and malignant skin tumors using the Food and Drug Administration Adverse Event Reporting System	4
Socioeconomic deprivation and its association with polypharmacy in England: results from a national cross-sectional survey	4
Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study	4
Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database	4
Real-world safety profile of mitomycin: signal detection and time-to-onset analysis from FDA adverse event reporting system and VigiAccess databases	4
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation	4
Exploring community pharmacy manager/ pharmacist perceptions and responses to China’s dual-channel policy for improving access and rational use of innovative drugs: a qualitative study	4
European Society of Clinical Pharmacy: ‘the prescribing pharmacist: a prescription for better patient care’	4
Identification and evaluation of medication-related issues relating to patient’s own drugs by pharmacy students while on placement in a tertiary hospital	4
Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogeno	4